title: High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus.
authors.forename: S
authors.initials: S
authors.lastname: Sookoian
authors.forename: V
authors.initials: V
authors.lastname: Neglia
authors.forename: G
authors.initials: G
authors.lastname: Castaño
authors.forename: B
authors.initials: B
authors.lastname: Frider
authors.forename: M C
authors.initials: MC
authors.lastname: Kien
authors.forename: E
authors.initials: E
authors.lastname: Chohuela
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000453:epidemiology* / Q000209:etiology; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin